Production (Stage)
BioXcel Therapeutics, Inc.
BTAI
$1.34
-$0.05-3.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.17% | -54.23% | -55.11% | -55.88% | -55.21% |
| Total Receivables | -- | 84.51% | -99.59% | 88.40% | 33.57% |
| Inventory | -73.68% | -65.90% | -24.43% | 39.22% | 24.95% |
| Prepaid Expenses | 125.25% | 90.15% | 16.25% | -24.96% | -53.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -25.38% | -30.70% | -35.61% | -64.56% | -62.92% |
| Total Current Assets | -53.31% | -48.17% | -51.60% | -53.57% | -54.35% |
|
|
|||||
| Total Current Assets | -53.31% | -48.17% | -51.60% | -53.57% | -54.35% |
| Net Property, Plant & Equipment | -46.78% | -41.78% | -37.62% | -34.25% | -30.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -90.59% |
| Total Assets | -53.15% | -47.98% | -51.33% | -53.29% | -54.29% |
|
|
|||||
| Total Accounts Payable | -10.28% | 17.11% | 39.55% | 18.33% | 122.42% |
| Total Accrued Expenses | -72.33% | -56.06% | -69.03% | -41.19% | -32.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,587.82% | -- | 8.55% | 8.73% | 8.62% |
| Total Finance Division Other Current Liabilities | 71.64% | -80.30% | 135.51% | -33.21% | -57.95% |
| Total Other Current Liabilities | 71.64% | -80.30% | 135.51% | -33.21% | -57.95% |
| Total Current Liabilities | -18.85% | -18.46% | -35.15% | -21.46% | 9.46% |
|
|
|||||
| Total Current Liabilities | -18.85% | -18.46% | -35.15% | -21.46% | 9.46% |
| Long-Term Debt | -1.69% | 1.90% | 5.40% | 6.36% | 6.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -85.23% | -69.57% | -58.51% | -50.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -84.57% | 248.19% | 115.44% | 353.41% | 724.48% |
| Total Liabilities | -16.77% | 0.94% | -4.63% | 4.10% | 21.71% |
|
|
|||||
| Common Stock & APIC | 4.08% | 4.31% | 4.92% | 5.28% | 5.35% |
| Retained Earnings | -6.49% | -10.09% | -12.49% | -20.82% | -32.96% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -24.61% | -64.76% | -110.88% | -1,367.07% | -236.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -24.61% | -64.76% | -110.88% | -1,367.07% | -236.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -24.61% | -64.76% | -110.88% | -1,367.07% | -236.52% |
|
|
|||||